ArticleClinical science (London, England : 1979)2022

Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease.

Jakob A Østergaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.